As expected, the albumin-binder-conjugated [177Lu]Lu-HTK03170 delivered a higher radiation dose (6.7-fold) to tumor than its non-albumin-binder-conjugated analog [177Lu]Lu-HTK03149. Here, ALB is linked to neoplasm.